Delivery Order SPE2DB20D2014-SPE2DB25FD06T
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,622.82 to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Entresto 24 mg-26 mg tablets (60-count packages). This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The order is scheduled for ultimate completion by June 18, 2025, with performance to be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,967.57 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180 count) under a firm fixed-price contract. The award was made on December 19, 2025, with an ultimate completion date of December 22, 2025, and represents a non-set-aside competitive award. AmerisourceBergen will fulfill this order from its Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $37,060.03 to supply Entresto 49 mg-51 mg tablets (60-count packages) with a firm fixed price and an ultimate completion date of December 12, 2025. This non-set-aside, competitively awarded contract was executed on December 11, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a continuation of the...
- The Defense Logistics Agency awarded a delivery order valued at $38,756.30 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180 count) under a firm fixed price contract. The award was made on August 11, 2025, with an ultimate completion date of August 12, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location in the same jurisdiction. This...
- The Defense Logistics Agency awarded a delivery order valued at $45,433.69 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180-count units). This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, was competitively awarded without any set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,294.80 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (60-count packages) under a firm fixed-price contract. The award was made on April 21, 2025, with an ultimate completion date of April 22, 2025, and represents a non-set-aside, competitively awarded contract. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,119.90 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (60-count packaging) on September 15, 2025, with completion scheduled for September 16, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under DLA's pharmaceutical procurement requirements. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,650.00 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180-count units). This competitively awarded, firm fixed-price delivery order was issued on December 22, 2025, with an ultimate completion date of December 23, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,809.30 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180 count) under a firm fixed price contract. The award was announced on May 12, 2025, with an ultimate completion date of May 13, 2025, and represents a non-competitive award executed under an existing contract vehicle. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $32,866.26 to supply Entresto 24 mg-26 mg tablets (60-count units) under a firm fixed price contract. The award, issued on September 19, 2025, with an ultimate completion date of September 22, 2025, represents a non-competitive delivery order. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FD06TDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $31,342.00 to supply Entresto 24 mg-26 mg tablets (60-count units) under a firm fixed price contract. The award, issued on September 22, 2025, with an ultimate completion date of September 23, 2025, represents a non-set-aside competitive procurement. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a diverse range of medications, vaccines, and medical supplies to support military healthcare programs. The parent contract demonstrates AmerisourceBergen's established capability to fulfill federal pharmaceutical requirements across multiple therapeutic domains and its role as a critical vendor for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.3k | 9/22/25 |